The first case of NSHL by direct impression on EYA1 gene and identification of one novel mutation in MYO7A in the Iranian families

Document Type: Original Article

Authors

1 Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

2 Department of Medical Genetics, DeNA Laboratory, Tehran, Iran

3 Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

Abstract

Objective(s): Targeted next-generation sequencing (NGS) provides a consequential opportunity to elucidate genetic factors in known diseases, particularly in profoundly heterogeneous disorders such as non-syndromic hearing loss (NSHL). Hearing impairments could be classified into syndromic and non-syndromic types. This study intended to assess the significance of mutations in these genes to the autosomal recessive/dominant non-syndromic genetic load among Iranian families.
Materials and Methods: Two families were involved in this research and two patients were examined by targeted next-generation sequencing. Here we report two novel mutations in the MYO7A and EYA1 genes in two patients detected by targeted NGS. They were confirmed by Sanger sequencing and quantitative real-time PCR techniques.
Results: In this investigation, we identified a novel mutation in MYO7A, c.3751G>C, p.A1251P, along with another previously identified mutation (c.1708C>T) in one of the cases. This mutation is located in the MYTH4 protein domain which is a pivotal domain for the myosin function. Another finding in this research was a novel de-novo deletion which deletes the entire EYA1 coding region (EX1-18 DEL). Mutations in EYA1 gene have been found in branchiootorenal (BOR) syndrome. Interestingly the patient with EYA1 deletion did not show any other additional clinical implications apart from HL. This finding might argue for the sole involvement of EYA1 function in the mechanism of hearing.
Conclusion: This investigation exhibited that the novel mutations in MYO7A, c.3751G>C, p.A1251P, and EYA1, EX1-18 DEL, were associated with NSHL. Our research increased the mutation spectrum of hearing loss in the Iranian population.

Keywords

Main Subjects


1.Smith RJ, Bale JF, White KR. Sensorineural hearing loss in children. The Lancet 2005; 365:879-890.

2.Kochhar A, Hildebrand MS, Smith RJ. Clinical aspects of hereditary hearing loss. Genetics in Medicine 2007; 9:393-408.

3.Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Annals of Otology, Rhinology & Laryngology 1977; 86:463-480.

4.Pandya A. Nonsyndromic hearing loss and deafness, mitochondrial.  1993.

5.Van Camp G, Smith RJ. Hereditary hearing loss homepage. 2006.

6.Cremers CWRJ, Smith R. Genetic hearing impairment: its clinical presentations: Karger Medical and Scientific Publishers; 2002.

7.Nance WE. The genetics of deafness. Mental retardation and developmental disabilities research reviews 2003; 9:109-119.

8.Zou D, Erickson C, Kim E-H, Jin D, Fritzsch B, Xu P-X. Eya1 gene dosage critically affects the development of sensory epithelia in the mammalian inner ear. Human Molecular Genetics 2008; 17:3340-3356.

9.Panel GEoCHLE. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetics in Medicine 2002; 4:162.

10.Tang HY, Fang P, Ward PA, Schmitt E, Darilek S, Manolidis S, et al. DNA sequence analysis of GJB2, encoding connexin 26: observations from a population of hearing impaired cases and variable carrier rates, complex genotypes, and ethnic stratification of alleles among controls. American Journal of Medical Genetics Part A 2006; 140:2401-2415.

11.Noori-Daloii M. Mutation analysis of GJB2 and GJB6 genes and the genetic linkage analysis of five common DFNB loci in the Iranian families with autosomal recessive non-syndromic hearing loss. Journal of Sciences, Islamic Republic of Iran 2010; 21.

12.Chaleshtori MH, Farhud D, Taylor R, Hadavi V, Patton M, Afzal A. Deafness–associated connexin 26 gene (GJB2) mutations in Iranian population. Iranian Journal of Public Health 2002; 31:75-79.

13.Liu Y, Wei X, Kong X, Guo X, Sun Y, Man J, et al. Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases. PLoS ONE 2015; 10:e0133636.

14.Stitziel NO, Kiezun A, Sunyaev S. Computational and statistical approaches to analyzing variants identified by exome sequencing. Genome biology 2011; 12:227.

15.Browser E. Exome Aggregation Consortium Website. 2015.

16.Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human gene mutation database (HGMD®): 2003 update. Human mutation 2003; 21:577-581.

17.Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nature methods 2010; 7:575-576.

18.Guex N, Peitsch MC. SWISS‐MODEL and the Swiss‐Pdb Viewer: an environment for comparative protein modeling. electrophoresis 1997; 18:2714-2723.

19.Haas J, Roth S, Arnold K, Kiefer F, Schmidt T, Bordoli L, et al. The Protein Model Portal—a comprehensive resource for protein structure and model information. Database 2013; 2013.

20.Wu L, Pan L, Wei Z, Zhang M. Structure of MyTH4-FERM domains in myosin VIIa tail bound to cargo. Science 2011; 331:757-760.

21.Kaplan W, Littlejohn TG. Swiss-PDB viewer (deep view). Briefings in bioinformatics 2001; 2:195-197.

22.Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Research 2005; 33:W306-W310.

23.Worth CL, Preissner R, Blundell TL. SDM—a server for predicting effects of mutations on protein stability and malfunction. Nucleic acids research 2011; 39:W215-W222.

24.Zambrano R, Jamroz M, Szczasiuk A, Pujols J, Kmiecik S, Ventura S. AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures. Nucleic acids research 2015; 43:W306-W313.

25.Weber KL, Sokac AM, Berg JS, Cheney RE, Bement WM. A microtubule-binding myosin required for nuclear anchoring and spindle assembly. Nature 2004; 431:325-329.

26.Van Laer L, Cryns K, Smith RJ, Van Camp G. Nonsyndromic hearing loss. Ear and hearing 2003; 24:275-288.

27.Ari Ş, Arikan M. Next-Generation Sequencing: Advantages, Disadvantages, and Future.  Plant Omics: Trends and Applications: Springer; 2016. p. 109-135.

28.Yan D, Tekin M, Blanton SH, Liu XZ. Next-generation sequencing in genetic hearing loss. Genetic testing and molecular biomarkers 2013; 17:581-587.

29.Well D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, et al. Defective myosin VIIA gene responsible for Usher syndrome type IB. Nature 1995; 374:60-61.

30.Hartman MA, Spudich JA. The myosin superfamily at a glance. J Cell Sci 2012; 125:1627-1632.

31.Gerber S, Bonneau D, Gilbert B, Munnich A, Dufier J-L, Rozet J-M, et al. USH1A: chronicle of a slow death. The American Journal of Human Genetics 2006; 78:357-359.

32.Asgharzade S, Reiisi S, Tabatabaiefar MA, Chaleshtori MH. Screening of Myo7A Mutations in Iranian Patients with Autosomal Recessive Hearing Loss from West of Iran. Iranian Journal of Public Health 2017; 46:76-82.

33.Mermall V, Post PL, Mooseker MS. Unconventional myosins in cell movement, membrane traffic, and signal transduction. Science 1998; 279:527-533.

34.Boëda B, El‐Amraoui A, Bahloul A, Goodyear R, Daviet L, Blanchard S, et al. Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle. The EMBO Journal 2002; 21:6689-6699.

35.Reiisi S, Tabatabaiefar MA, Sanati MH, Chaleshtori MH. Screening of DFNB3 in Iranian families with autosomal recessive non-syndromic hearing loss reveals a novel pathogenic mutation in the MyTh4 domain of the MYO15A gene in a linked family. Iranian journal of basic medical sciences 2016; 19:772.

36.Planelles-Herrero VJ, Blanc F, Sirigu S, Sirkia H, Clause J, Sourigues Y, et al. Myosin MyTH4-FERM structures highlight important principles of convergent evolution. Proceedings of the National Academy of Sciences of the United States of America 2016; 113:E2906-E2915.

37.Yu I-M, Planelles-Herrero VJ, Sourigues Y, Moussaoui D, Sirkia H, Kikuti C, et al. Myosin 7 and its adaptors link cadherins to actin. Nature Communications 2017; 8:ncomms15864.

38.Cordes FS, Bright JN, Sansom MS. Proline-induced distortions of transmembrane helices. Journal of molecular biology 2002; 323:951-960.

39.Fukuoka H, Kanda Y, Ohta S, Usami S-i. Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese. Journal of human genetics 2007; 52:510-515.

40.Goncalves A, Matos T, Simoes-Teixeira H, Machado MP, Simao M, Dias O, et al. WFS1 and non-syndromic low-frequency sensorineural hearing loss: a novel mutation in a Portuguese case. Gene 2014; 538:288-291.

41.Cryns K, Pfister M, Pennings RJ, Bom SJ, Flothmann K, Caethoven G, et al. Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations. Human genetics 2002; 110:389-394.

42.Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, Vincent C, et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nature genetics 1997; 15:157-164.

43.Xu P-X, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nature genetics 1999; 23:113-117.

44.Pourquié O. Publisher’s Note: Eya1 controls cell polarity, spindle orientation, cell fate and Notch signaling in distal embryonic lung epithelium by El-Hashash et al. Development doi: 10.1242/dev. 058479. Dev Biol 2017; 350:112-126.

45.Spahiu L, Merovci B, Ismaili Jaha V, Batalli Këpuska A, Jashari H. Case report of a novel mutation of the EYA1 gene in a patient with branchio-oto-renal syndrome. Balkan Journal of Medical Genetics 2016; 19:91-94.

46.Krug P, Morinière V, Marlin S, Koubi V, Gabriel HD, Colin E, et al. Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harboring branchio‐oto‐renal syndrome calls into question the pathogenic role of SIX5 mutations. Human mutation 2011; 32:183-190.

47.Song MH, Kwon T-J, Kim HR, Jeon JH, Baek J-I, Lee W-S, et al. Mutational analysis of EYA1, SIX1 and SIX5 genes and strategies for management of hearing loss in patients with BOR/BO syndrome. PloS one 2013; 8:e67236.

48.Sanggaard KM, Rendtorff ND, Kjaer KW, Eiberg H, Johnsen T, Gimsing S, et al. Branchio–oto–renal syndrome: detection of EYA1 and SIX1 mutations in five out of six Danish families by combining linkage, MLPA and sequencing analyses. European Journal of Human Genetics 2007; 15:1121-1131.

49.Matsunaga T, Okada M, Usami S-I, Okuyama T. Phenotypic consequences in a Japanese family having branchio-oto-renal syndrome with a novel frameshift mutation in the gene EYA1. Acta oto-laryngologica 2007; 127:98-104.

50.Kwon M-J, Boo SH, Kwon M-J, Boo SH, Kim H-J, Cho Y-S, et al. A novel splice site mutation in the EYA1 gene in a Korean family with branchio-oto (BO) syndrome. Acta oto-laryngologica 2009; 129:688-693.

51.Washington NL, Haendel MA, Mungall CJ, Ashburner M, Westerfield M, Lewis SE. Linking human diseases to animal models using ontology-based phenotype annotation. PLoS Biol 2009; 7:e1000247.

52.Chen A, Francis M, Ni L, Cremers CW, Kimberling WJ, Sato Y, et al. Phenotypic manifestations of branchiootorenal syndrome. American Journal of Medical Genetics Part A 1995; 58:365-370.

53.Propst EJ, Blaser S, Gordon KA, Harrison RV, Papsin BC. Temporal Bone Findings on Computed Tomography Imaging in Branchio‐Oto‐Renal Syndrome. The Laryngoscope 2005; 115:1855-1862.


54.Ou Z, Martin DM, Bedoyan JK, Cooper ML, Chinault AC, Stankiewicz P, et al. Branchiootorenal syndrome and oculoauriculovertebral spectrum features associated with duplication of SIX1, SIX6, and OTX2 resulting from a complex chromosomal rearrangement. American Journal of Medical Genetics Part A 2008; 146:2480-2489.